BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31784426)

  • 1. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.
    Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A
    Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma.
    Lasorsa VA; Montella A; Cantalupo S; Tirelli M; de Torres C; Aveic S; Tonini GP; Iolascon A; Capasso M
    Cancer Res; 2022 Apr; 82(7):1193-1207. PubMed ID: 35101866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
    Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
    Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers.
    Umer HM; Cavalli M; Dabrowski MJ; Diamanti K; Kruczyk M; Pan G; Komorowski J; Wadelius C
    Hum Mutat; 2016 Sep; 37(9):904-13. PubMed ID: 27174533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
    Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
    Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
    Mus LM; Lambertz I; Claeys S; Kumps C; Van Loocke W; Van Neste C; Umapathy G; Vaapil M; Bartenhagen C; Laureys G; De Wever O; Bexell D; Fischer M; Hallberg B; Schulte J; De Wilde B; Durinck K; Denecker G; De Preter K; Speleman F
    Sci Rep; 2020 Jan; 10(1):218. PubMed ID: 31937834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional annotation of noncoding mutations in cancer.
    Umer HM; Smolinska K; Komorowski J; Wadelius C
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
    Kaiser VB; Taylor MS; Semple CA
    PLoS Genet; 2016 Aug; 12(8):e1006207. PubMed ID: 27490693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
    Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
    Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
    Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and structural considerations of TF-DNA binding for the generation of biologically meaningful and accurate phylogenetic footprinting analysis: the LysR-type transcriptional regulator family as a study model.
    Oliver P; Peralta-Gil M; Tabche ML; Merino E
    BMC Genomics; 2016 Aug; 17(1):686. PubMed ID: 27567672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA pancEts-1 Promotes Neuroblastoma Progression through hnRNPK-Mediated β-Catenin Stabilization.
    Li D; Wang X; Mei H; Fang E; Ye L; Song H; Yang F; Li H; Huang K; Zheng L; Tong Q
    Cancer Res; 2018 Mar; 78(5):1169-1183. PubMed ID: 29311158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma.
    Tsubota S; Kishida S; Shimamura T; Ohira M; Yamashita S; Cao D; Kiyonari S; Ushijima T; Kadomatsu K
    Cancer Res; 2017 Oct; 77(19):5259-5271. PubMed ID: 28807939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.
    Hsu CL; Chang HY; Chang JY; Hsu WM; Huang HC; Juan HF
    Oncotarget; 2016 Jun; 7(24):36293-36310. PubMed ID: 27167114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of neuroblastoma development.
    Durinck K; Speleman F
    Cell Tissue Res; 2018 May; 372(2):309-324. PubMed ID: 29350283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes.
    Polak P; Domany E
    BMC Genomics; 2006 Jun; 7():133. PubMed ID: 16740159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.